Phase II trial of radiotherapy after hyperbaric oxygenation with chemotherapy for high-grade gliomas

British Journal of Cancer

Volumn 95, Issue 7, 2006, Pages 862-868

  Ogawa, K ^a   Yoshii, Y ^b   Inoue, O ^b   Toita, T ^a   Saito, A ^b   Kakinohana, Y ^a   Adachi, G ^c   Iraha, S ^a   Tamaki, W ^a   Sugimoto, K ^b   Hyodo, A ^b   Murayama, S ^a  

^a UNIVERSITY OF THE RYUKYUS SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF THE RYUKYUS   (Japan)

^c Naha City Hospital   (Japan)

Author keywords

Chemotherapy; Glioblastoma; Glioma; Hyperbaric oxygen; Radiation therapy

Indexed keywords

NIMUSTINE; PROCARBAZINE; VINCRISTINE;

ADULT; AGED; ALOPECIA; ANEMIA; ARTICLE; BAROTRAUMA; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ERYTHEMA; FEMALE; FOLLOW UP; GLIOBLASTOMA; GLIOMA; HISTOPATHOLOGY; HUMAN; HYPERBARIC OXYGEN; KARNOFSKY PERFORMANCE STATUS; LEUKOPENIA; LIVER DYSFUNCTION; LIVER TOXICITY; MALE; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; NAUSEA; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE FRACTIONATION; RADIATION INJURY; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT OUTCOME; UNIVARIATE ANALYSIS;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; GLIOMA; HUMANS; HYPERBARIC OXYGENATION; MALE; MIDDLE AGED; NIMUSTINE; PROCARBAZINE; RADIOTHERAPY; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VINCRISTINE;

EID: 33749364915     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603342     Document Type: Article

References (45)

1. Al-Waili NS, Butler GJ, Beale J, Hamilton RW, Lee BY, Lucas P (2005) Hyperbaric oxygen and malignancies: a potential role in radiotherapy, chemotherapy, tumor surgery and phototherapy. Med Sci Monit 11: RA279-RA289
2. Bennett M, Feldmeier J, Smee R, Milross C, Bennett M (2005) Hyperbaric oxygenation for tumour sensitization to radiotherapy. Cochrane Database Syst Rev 19: CD005007
3. Beppu T, Kamada K, Nakamura R, Oikawa H, Takeda M, Fukuda T, Aradi H, Ogasawara K, Ogawa A (2003) A phase II study of radiotherapy after hyperbaric oxygenation combined with interferon-beta and nimustine hydrochloride to treat supratentorial malignant gliomas. J Neurooncol 61: 161-170
4. Beppu T, Kamada K, Yoshida Y, Arai H, Ogasawara K, Ogawa A (2002) Changes of oxygen pressure in glioblastoma tissue under various conditions. J Neurooncol 58: 47-52
5. Buckner JC (2003) Factors influencing survival in high-grade gliomas. Semin Oncol 30(6 Suppl 19): 10-14
6. Choi IS, Lee SH, Kim TY, Bang JS, Paek SH, Kim S, Kim IH, Heo DS, Bang YJ, Kim DG, Jung HW, Kim NY (2002) Phase II study of chemotherapy with ACNU plus cisplatin followed by cranial irradiation in patients with newlydiagnosed glioblastoma multiforme. J Neurooncol 60: 171-176
7. Collingridge DR, Piepmeier JM, Rockwell S, Knisely JP (1999) Polarographic measurements of oxygen tension in human glioma and surrounding peritumoral brain tissue. Radiother Oncol 53: 127-131
8. Cox DR (1972) Regression models and life tables. J R Stat Soc 34: 187-220
9. Curren Jr WJ, Scott CB, Horton J, Nelson JS, Weinstein AS, Fishbach AJ, Chang CH, Rotman M, Asbell SO, Krisch RE (1993) Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 85: 704-710
10. Dische S (1991) What have we learnt from hyperbaric oxygen? Radiother Oncol 20(Suppl 1): 71-74
11. Dowling S, Fischer JJ, Rockwell S (1992) Fluosol and hyperbaric oxygen as an adjunct to radiation therapy in the treatment of malignant gliomas: a pilot study. Biomater Artif Cells Immobilizat Biotechnol 20: 903-905
12. Fine HA (1994) The basis for current treatment recommendations for malignant gliomas. J Neurooncol 20: 111-120
13. Fine HA, Dear KB, Loeffler JS, Black PM, Canellos GP (1993) Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 71: 2585-2597
14. Gray LH, Conger AD, Ebert M, Hornsey S, Scott OC (1953) The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol 26: 638-648
15. Grossman SA, O'Neill A, Grunnet M, Mehta M, Pearlman JL, Wagner H, Gilbert M, Newton HB, Hellman R (2003) Phase III study comparing three cycles of infusional carmustine and cisplatin followed by radiation therapy with radiation therapy and concurrent carmustine in patients with newly diagnosed supratentorial glioblastoma multiforme: Eastern Cooperative Oncology Group Trial 2394. J Clin Oncol 21: 1485-1491
16. Hall EJ (1994) Radiobiology for the Radiologist, 4th ed Lippincott: Philadelphia, pp. 408-417
17. Hartmann KA, van der Kleij AJ, Carl UM, Hulshof MC, Willers R, Sminia P (2001) Effects of hyperbaric oxygen and normobaric carbogenon the radiation response of the rat rhabdomyosarcoma R1 H. Int J Radiat Oncol Biol Phys 51: 1037-1044
18. Henk JM, Kunkler PB, Smith CW (1977) Radiotherapy and hyperbaric oxygen in head and neck cancer. Final report of first controlled clinical trial. Lancet 2: 101-103
19. 15O and positron emission tomography: analytical techniques and preliminary results. Neuroradiology 23: 63-74
20. Jain KK (1990) Textbook of Hyperbaric Medicine. Hogrefe & Huber Publishers: Toronto, pp. 408-417
21. Jamieson D, van den Brenk HAS (1963) Measurement of oxygen tensions in cerebral tissues of rats exposed to high pressures of oxygen. J Appl Physiol 18: 869-876
22. Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481
23. Kayama T, Yoshimoto T, Fujimoto S, Sakurai Y (1991) Intratumoral oxygen pressure in malignant brain tumor. J Neurosurg 74: 55-59
24. Kinoshita Y, Kohshi K, Kunugita N, Tosaki T, Yokota A (2000) Preservation of tumour oxygen after hyperbaric oxygenation monitored by magnetic resonance imaging. Br J Cancer 82: 88-92
25. Kleinberg L, Grossman SA, Piantadosi S, Zeltzman M, Wharam M (1999) The effects of sequential vs concurrent chemotherapy and radiotherapy on survival and toxicity in patients with newly diagnosed high-grade astrocytoma. Int J Radiat Oncol Biol Phys 44: 535-543
26. Kohshi K, Kinoshita Y, Imada H, Kunugita N, Abe H, Terashima H, Tokui N, Uemura S (1999) Effects of radiotherapy after hyperbaric oxygenation on malignant gliomas. Br J Cancer 80: 236-241
27. Kristiansen K, Hagen S, Kollevold T, Torvik A, Holme I, Nesbakken R, Hatlevoll R, Lindgren M, Brun A, Lindgren S, Notter G, Andersen AP, Elgen K (1981) Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian glioblastoma study group. Cancer 47: 649-652
28. Kunugita N, Kohshi K, Kinoshita Y, Katoh T, Abe H, Tosaki T, Kawamoto K, Norimura T (2001) Radiotherapy after hyperbaric oxygenation improves radioresponse in experimental tumor models. Cancer Lett 164: 149-154
29. Laperriere N, Zuraw L, Cairncross G (2002) Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review. Radiother Oncol 64: 259-273
30. Lassen U, Kristjansen PE, Wagner A, Kosteljanetz M, Poulsen HS (1999) Treatment of newly diagnosed glioblastoma multiforme with carmustine, cisplatin and etoposide followed by radiotherapy. A phase II study. J Neurooncol 43: 161-166
31. Lindegaard JC, Overgaard J, Bentzen SM, Pedersen D (1996) Is there a radiobiologic basis for improving the treatment of advanced stage cervical cancer? J Natl Cancer Inst Monogr 21: 105-112
32. Macdonald DR, Cascino TL, Schold Jr SC, Cairncross JG. (1990) Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 21: 3547-3549
33. Mantel N (1966) Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50: 163-170
34. Mayer R, Hamilton-Farrell MR, van der Kleij AJ, Schmutz J, Granstrom G, Sicko Z, Melamed Y, Carl UM, Hartmann KA, Jansen EC, Ditri L, Sminia P (2005) Hyperbaric oxygen and radiotherapy. Strahlenther Onkol 181: 113-123
35. Mineura K, Sasajima T, Kowada M, Ogawa T, Hatazawa J, Shishido F, Uemura K (1994) Perfusion and metabolism in predicting the survival of patients with cerebral gliomas. Cancer 73: 2386-2394
36. Ogawa K, Yoshii Y, Inoue O, Toita T, Saito A, Kakinohana Y, Adachi G, Ishikawa Y, Kin S, Murayama S (2003) Prospective trial of radiotherapy after hyperbaric oxygenation with chemotherapy for high-grade gliomas. Radiother Oncol 67: 63-67
37. Overgaard J, Horsman MR (1996) Modification of hypoxia-induced radioresistance in tumors by the use of oxygen and sentitizers. Semin Radiat Oncol 6: 10-21
38. 2 distribution and bioreductive enzymes in human malignant brain tumors. Int J Radiat Oncol Biol Phys 29: 427-431
39. Scott CB, Scarantino C, Urtasun R, Movsas B, Jones CU, Simpson JR, Fischbach AJ, Curran Jr WJ (1998) Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90-06. Int J Radiat Oncol Biol Phys 40: 51-55
40. Stewart LA (2002) Chemotherapy in adult high-grade glioma: a systemic review and meta-analysis of individual patient data from 12 randomized trials. Lancet 359: 1011-1018
41. Stupp R, Mason W, van der Bent MJ, Weller M, Fisher B, Taphoorn MJB, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curshmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross G, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996
42. Tyler JL, Diksic M, Villemure JG, Evans AC, Meyer E, Yamanoto YL, Feindel W (1987) Metabolic and hemodynamic evaluation of gliomas using positron emission tomography. J Nucl Med 33: 1123-1133
43. Walker MD, Alexander Jr E, Hunt WE, MacCarty CS, Mahaley Jr MS, Mealey Jr J, Norrell HA, Owens G, Ransohoff J, Wilson CB, Gehan EA, Strike TA (1978) Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas: a cooperative clinical trial. J Neurosurg 49: 333-343
44. Weller M, Muller B, Koch R, Bamberg M, Krauseneck P (2003) Neuro-Oncology Working Group 01 trial of nimustine plus tenitoside vs nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first line treatment of malignant glioma. J Clin Oncol 21: 3276-3284
45. Wick W, Hermisson M, Kortmann RD, Kuker WM, Duffner F, Dichgans J, Bamberg M, Weller M (2002) Neoadjuvant gemcitabine/treosulfan chemotherapy for newly diagnosed glioblastoma: a phase II study. J Neurooncol 59: 151-155